● Pelzont (1. 000 mg/ 20 mg til 2. 000 mg/ 40 mg ved uge 5) ▲Nicotinsyre (depotformulering 1. 000mg to 2. 000 mg ved uge 5) ○Placebo * Inkluderer patienter med moderate, svære eller ekstreme flushing- symptomer † Øgning af dosis ved uge 5
● Pelzont (1000 mg/ 20 mg to 2000 mg/ 40 mg at week 5) ▲ Nicotinic acid (prolonged-release 1000 mg to 2000 mg at week 5) ○ Placebo *Includes patients with moderate, severe, or extreme flushing symptoms † Dose advancement at Week 5